CRP and acute respiratory distress syndrome: In COVID-19 acute respiratory distress syndrome (ARDS), lipidomic analysis of tracheal aspirates revealed distinct lipid changes associated with VAP, with sphingomyelin (34:1) and PC (O-34:1) outperforming C-reactive protein (CRP) and procalcitonin (PCT) as biomarkers.